174 related articles for article (PubMed ID: 11346980)
1. [Contribution of heparin therapy in the medical treatment of Buruli ulcer apropos of 1 case].
Kanga JM; Dion-Laine M; Kacou DE; Menan EI
Bull Soc Pathol Exot; 2001 Mar; 94(1):32-5. PubMed ID: 11346980
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of inhibitory effect of rifalazil and rifampicin against Mycobacterium ulcerans infection induced in mice].
Nakanaga K; Saito H; Ishii N; Goto M
Kekkaku; 2004 May; 79(5):333-9. PubMed ID: 15211873
[TBL] [Abstract][Full Text] [Related]
3. Orally administered combined regimens for treatment of Mycobacterium ulcerans infection in mice.
Ji B; Chauffour A; Robert J; Lefrançois S; Jarlier V
Antimicrob Agents Chemother; 2007 Oct; 51(10):3737-9. PubMed ID: 17664316
[TBL] [Abstract][Full Text] [Related]
4. [Recurrence after surgical treatment of Buruli ulcer in Cote d'Ivoire].
Kanga JM; Kacou DE; Sangaré A; Dabila Y; Asse NH; Djakeaux S
Bull Soc Pathol Exot; 2003 Jan; 96(5):406-9. PubMed ID: 15015849
[TBL] [Abstract][Full Text] [Related]
5. [Buruli ulcers in Burkina Faso: apropos of 6 cases].
Ouoba K; Sano D; Traoré A; Ouédraogo R; Sakandé B; Sanou A
Tunis Med; 1998 Mar; 76(3):46-50. PubMed ID: 9844533
[No Abstract] [Full Text] [Related]
6. Post-surgical assessment of excised tissue from patients with Buruli ulcer disease: progression of infection in macroscopically healthy tissue.
Bretzel G; Siegmund V; Racz P; van Vloten F; Ngos F; Thompson W; Biason P; Adjei O; Fleischer B; Nitschke J
Trop Med Int Health; 2005 Nov; 10(11):1199-206. PubMed ID: 16262747
[TBL] [Abstract][Full Text] [Related]
7. [Epidemiologicl aspects of Buruli ulcer in Côte d'Ivoire: results of a national survey].
Kanga JM; Kacou ED
Bull Soc Pathol Exot; 2001 Mar; 94(1):46-51. PubMed ID: 11346983
[TBL] [Abstract][Full Text] [Related]
8. [Mycobacterium ulcerans cutaneous infections: Buruli ulcers].
Josse R; Guedenon A; Darie H; Anagonou S; Portaels F; Meyers WM
Med Trop (Mars); 1995; 55(4):363-73. PubMed ID: 8830223
[TBL] [Abstract][Full Text] [Related]
9. High rates of apoptosis in human Mycobacterium ulcerans culture-positive buruli ulcer skin lesions.
Walsh DS; Meyers WM; Portaels F; Lane JE; Mongkolsirichaikul D; Hussem K; Gosi P; Myint KS
Am J Trop Med Hyg; 2005 Aug; 73(2):410-5. PubMed ID: 16103613
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans.
Etuaful S; Carbonnelle B; Grosset J; Lucas S; Horsfield C; Phillips R; Evans M; Ofori-Adjei D; Klustse E; Owusu-Boateng J; Amedofu GK; Awuah P; Ampadu E; Amofah G; Asiedu K; Wansbrough-Jones M
Antimicrob Agents Chemother; 2005 Aug; 49(8):3182-6. PubMed ID: 16048922
[TBL] [Abstract][Full Text] [Related]
11. [The contribution of skin autograft in open air in the treatment of the Buruli ulcer].
Kibadi Kapay A; Mputu-Yamba JB; Muyembe T; Bonga G; N'Siala A
Bull Soc Pathol Exot; 2005 Apr; 98(1):21-5. PubMed ID: 15915968
[TBL] [Abstract][Full Text] [Related]
12. [Facial localizations of Buruli ulcers: two cases].
Ouattara D; Aka GK; Meningaud JP; Sica A; Kaba L; Gadegbeku S
Rev Stomatol Chir Maxillofac; 2003 Sep; 104(4):231-4. PubMed ID: 14631235
[TBL] [Abstract][Full Text] [Related]
13. Clinical and histologic features of skin lesions in a cynomolgus monkey experimentally infected with mycobacterium ulcerans (Buruli ulcer) by intradermal inoculation.
Walsh DS; Dela Cruz EC; Abalos RM; Tan EV; Walsh GP; Portaels F; Meyers WM
Am J Trop Med Hyg; 2007 Jan; 76(1):132-4. PubMed ID: 17255241
[TBL] [Abstract][Full Text] [Related]
14. Short report: edematous Mycobacterium ulcerans infection (Buruli ulcer) on the face: a case report.
Phanzu DM; Ablordey A; Imposo DB; Lefevre L; Mahema RL; Suykerbuyk P; Meyers WM; Portaels F
Am J Trop Med Hyg; 2007 Dec; 77(6):1099-102. PubMed ID: 18165530
[TBL] [Abstract][Full Text] [Related]
15. Mycobacterium ulcerans infection: treatment with rifampin, hyperbaric oxygenation, and heat.
Krieg RE; Wolcott JH; Meyers WM
Aviat Space Environ Med; 1979 Sep; 50(9):888-92. PubMed ID: 496758
[TBL] [Abstract][Full Text] [Related]
16. [Buruli ulcer: epidemiological, clinical and therapeutic aspects in the Ivory Coast].
Kanga JM; Kacou ED; Kouame K; Kassi E; Kaloga M; Yao JK; Dion-Laine M; Avoaka LE; Yoboue-Yao P; Sangare A; Ecra JE; Ahogo C; Djedje MS; Kadiri AJ; Aye C
Med Trop (Mars); 2004; 64(3):238-42. PubMed ID: 15497322
[No Abstract] [Full Text] [Related]
17. Contiguous spread of Mycobacterium ulcerans in Buruli ulcer lesions analysed by histopathology and real-time PCR quantification of mycobacterial DNA.
Rondini S; Horsfield C; Mensah-Quainoo E; Junghanss T; Lucas S; Pluschke G
J Pathol; 2006 Jan; 208(1):119-28. PubMed ID: 16261539
[TBL] [Abstract][Full Text] [Related]
18. [Buruli ulcer emerging from obscurity].
Johannessen A
Tidsskr Nor Laegeforen; 2006 Aug; 126(16):2148. PubMed ID: 16967521
[No Abstract] [Full Text] [Related]
19. [Mycobacterium ulcerans disease (Buruli ulcer): surgical treatment of 102 cases in the Democratic Republic of Congo].
Kibadi K
Med Trop (Mars); 2005 Nov; 65(5):444-8. PubMed ID: 16465813
[TBL] [Abstract][Full Text] [Related]
20. Bactericidal activity of rifampin-amikacin against Mycobacterium ulcerans in mice.
Dega H; Bentoucha A; Robert J; Jarlier V; Grosset J
Antimicrob Agents Chemother; 2002 Oct; 46(10):3193-6. PubMed ID: 12234844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
